Bullish option flow detected in Altimmune (ALT) with 8,561 calls trading, 3x expected, and implied vol increasing almost 4 points to 114.21%. Mar-25 6 calls and 3/28 weekly 5 puts are the most active options, with total volume in those strikes near 4,300 contracts. The Put/Call Ratio is 0.21. Earnings are expected on May 15th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT:
- Altimmune’s Promising R&D Developments and Market Opportunities Drive Buy Rating
- Altimmune call volume above normal and directionally bullish
- Evercore bullish on Altimmune, likes drug move into alcohol related disease
- Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
- Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion